• 廣西醫(yī)科大學(xué)第一附屬醫(yī)院胃腸腺體外科(南寧530021);

目的  探討原發(fā)性甲狀旁腺功能亢進(jìn)癥(PHPT)的診治經(jīng)驗(yàn)。
方法  回顧性分析我院近15年間18例手術(shù)治療的PHPT患者的臨床資料。
結(jié)果  初診病例術(shù)前核素99Tcm-sestamibi掃描和B超檢查陽(yáng)性定位診斷率分別為100%(9/9)和88%(15/17)。18例均經(jīng)手術(shù)治療,其中1例為再手術(shù)病例。術(shù)后病理診斷甲狀旁腺腺瘤13例,其中1例為雙腺瘤; 甲狀旁腺增生4例; 甲狀旁腺腺癌1例。首次手術(shù)治愈率為88%(15/17)。2例甲狀旁腺增生病例未治愈。再手術(shù)1例因損傷了單側(cè)喉返神經(jīng)致術(shù)后聲音嘶啞。
結(jié)論  術(shù)前核素99Tcm-sestamibi掃描和B超檢查對(duì)制定手術(shù)方案有重要意義,大多數(shù)PHPT病例適合行單側(cè)頸部探查術(shù)。甲狀旁腺增生病例的手術(shù)治愈率低。

引用本文: 解乃昌,林進(jìn)令,陸云飛. 18例原發(fā)性甲狀旁腺功能亢進(jìn)癥的診治分析. 中國(guó)普外基礎(chǔ)與臨床雜志, 2007, 14(1): 87-88. doi: 復(fù)制

1.  AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism [J]. Endocr Pract, 2005; 11(1)∶49.
2.  Inabnet WB. Intraoperative parathyroid hormone monitoring [J]. World J Surg, 2004; 28(12)∶1212.
3.  Parikshak M, Castillo ED, Conrad MF, et al. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for priary hyperparathyroidism [J]. Am Surg, 2003; 69(5)∶393.
  1. 1.  AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism [J]. Endocr Pract, 2005; 11(1)∶49.
  2. 2.  Inabnet WB. Intraoperative parathyroid hormone monitoring [J]. World J Surg, 2004; 28(12)∶1212.
  3. 3.  Parikshak M, Castillo ED, Conrad MF, et al. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for priary hyperparathyroidism [J]. Am Surg, 2003; 69(5)∶393.